Synthego was a Redwood City CRISPR-tools company supplying synthetic guide RNA and engineered cells plus the Eclipse automation platform; it filed Chapter 11 in May 2025 and was sold to creditor Perceptive Advisors.
Cloud bioreactors and Console software that let teams run and monitor bioprocess development experiments remotely.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →